1116 related articles for article (PubMed ID: 20097417)
1. Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial.
Bouadma L; Luyt CE; Tubach F; Cracco C; Alvarez A; Schwebel C; Schortgen F; Lasocki S; Veber B; Dehoux M; Bernard M; Pasquet B; Régnier B; Brun-Buisson C; Chastre J; Wolff M;
Lancet; 2010 Feb; 375(9713):463-74. PubMed ID: 20097417
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial.
de Jong E; van Oers JA; Beishuizen A; Vos P; Vermeijden WJ; Haas LE; Loef BG; Dormans T; van Melsen GC; Kluiters YC; Kemperman H; van den Elsen MJ; Schouten JA; Streefkerk JO; Krabbe HG; Kieft H; Kluge GH; van Dam VC; van Pelt J; Bormans L; Otten MB; Reidinga AC; Endeman H; Twisk JW; van de Garde EMW; de Smet AMGA; Kesecioglu J; Girbes AR; Nijsten MW; de Lange DW
Lancet Infect Dis; 2016 Jul; 16(7):819-827. PubMed ID: 26947523
[TBL] [Abstract][Full Text] [Related]
3. Stop Antibiotics on guidance of Procalcitonin Study (SAPS): a randomised prospective multicenter investigator-initiated trial to analyse whether daily measurements of procalcitonin versus a standard-of-care approach can safely shorten antibiotic duration in intensive care unit patients--calculated sample size: 1816 patients.
Assink-de Jong E; de Lange DW; van Oers JA; Nijsten MW; Twisk JW; Beishuizen A
BMC Infect Dis; 2013 Apr; 13():178. PubMed ID: 23590389
[TBL] [Abstract][Full Text] [Related]
4. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.
Schuetz P; Müller B; Christ-Crain M; Stolz D; Tamm M; Bouadma L; Luyt CE; Wolff M; Chastre J; Tubach F; Kristoffersen KB; Burkhardt O; Welte T; Schroeder S; Nobre V; Wei L; Bhatnagar N; Bucher HC; Briel M
Evid Based Child Health; 2013 Jul; 8(4):1297-371. PubMed ID: 23877944
[TBL] [Abstract][Full Text] [Related]
5. Procalcitonin guided antibiotic therapy and hospitalization in patients with lower respiratory tract infections: a prospective, multicenter, randomized controlled trial.
Schuetz P; Christ-Crain M; Wolbers M; Schild U; Thomann R; Falconnier C; Widmer I; Neidert S; Blum CA; Schönenberger R; Henzen C; Bregenzer T; Hoess C; Krause M; Bucher HC; Zimmerli W; Müller B;
BMC Health Serv Res; 2007 Jul; 7():102. PubMed ID: 17615073
[TBL] [Abstract][Full Text] [Related]
6. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial.
Schuetz P; Christ-Crain M; Thomann R; Falconnier C; Wolbers M; Widmer I; Neidert S; Fricker T; Blum C; Schild U; Regez K; Schoenenberger R; Henzen C; Bregenzer T; Hoess C; Krause M; Bucher HC; Zimmerli W; Mueller B;
JAMA; 2009 Sep; 302(10):1059-66. PubMed ID: 19738090
[TBL] [Abstract][Full Text] [Related]
7. Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: a randomized trial.
Jensen JU; Hein L; Lundgren B; Bestle MH; Mohr TT; Andersen MH; Thornberg KJ; Løken J; Steensen M; Fox Z; Tousi H; Søe-Jensen P; Lauritsen AØ; Strange D; Petersen PL; Reiter N; Hestad S; Thormar K; Fjeldborg P; Larsen KM; Drenck NE; Ostergaard C; Kjær J; Grarup J; Lundgren JD;
Crit Care Med; 2011 Sep; 39(9):2048-58. PubMed ID: 21572328
[TBL] [Abstract][Full Text] [Related]
8. Procalcitonin-guided decision making for duration of antibiotic therapy in neonates with suspected early-onset sepsis: a multicentre, randomised controlled trial (NeoPIns).
Stocker M; van Herk W; El Helou S; Dutta S; Fontana MS; Schuerman FABA; van den Tooren-de Groot RK; Wieringa JW; Janota J; van der Meer-Kappelle LH; Moonen R; Sie SD; de Vries E; Donker AE; Zimmerman U; Schlapbach LJ; de Mol AC; Hoffman-Haringsma A; Roy M; Tomaske M; Kornelisse RF; van Gijsel J; Visser EG; Willemsen SP; van Rossum AMC;
Lancet; 2017 Aug; 390(10097):871-881. PubMed ID: 28711318
[TBL] [Abstract][Full Text] [Related]
9. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.
Schuetz P; Müller B; Christ-Crain M; Stolz D; Tamm M; Bouadma L; Luyt CE; Wolff M; Chastre J; Tubach F; Kristoffersen KB; Burkhardt O; Welte T; Schroeder S; Nobre V; Wei L; Bhatnagar N; Bucher HC; Briel M
Cochrane Database Syst Rev; 2012 Sep; 2012(9):CD007498. PubMed ID: 22972110
[TBL] [Abstract][Full Text] [Related]
10. Procalcitonin-based therapeutic strategy to reduce antibiotic use in patients after cardiac surgery: a randomized controlled trial.
Maravić-Stojković V; Lausević-Vuk L; Jović M; Ranković A; Borzanović M; Marinković J
Srp Arh Celok Lek; 2011; 139(11-12):736-42. PubMed ID: 22338468
[TBL] [Abstract][Full Text] [Related]
11. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.
Schuetz P; Wirz Y; Sager R; Christ-Crain M; Stolz D; Tamm M; Bouadma L; Luyt CE; Wolff M; Chastre J; Tubach F; Kristoffersen KB; Burkhardt O; Welte T; Schroeder S; Nobre V; Wei L; Bucher HC; Bhatnagar N; Annane D; Reinhart K; Branche A; Damas P; Nijsten M; de Lange DW; Deliberato RO; Lima SS; Maravić-Stojković V; Verduri A; Cao B; Shehabi Y; Beishuizen A; Jensen JS; Corti C; Van Oers JA; Falsey AR; de Jong E; Oliveira CF; Beghe B; Briel M; Mueller B
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD007498. PubMed ID: 29025194
[TBL] [Abstract][Full Text] [Related]
12. Procalcitonin algorithm in critically ill adults with undifferentiated infection or suspected sepsis. A randomized controlled trial.
Shehabi Y; Sterba M; Garrett PM; Rachakonda KS; Stephens D; Harrigan P; Walker A; Bailey MJ; Johnson B; Millis D; Ding G; Peake S; Wong H; Thomas J; Smith K; Forbes L; Hardie M; Micallef S; Fraser JF; ;
Am J Respir Crit Care Med; 2014 Nov; 190(10):1102-10. PubMed ID: 25295709
[TBL] [Abstract][Full Text] [Related]
13. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial.
Christ-Crain M; Jaccard-Stolz D; Bingisser R; Gencay MM; Huber PR; Tamm M; Müller B
Lancet; 2004 Feb; 363(9409):600-7. PubMed ID: 14987884
[TBL] [Abstract][Full Text] [Related]
14. Antibiotic treatment of severe exacerbations of chronic obstructive pulmonary disease with procalcitonin: a randomized noninferiority trial.
Verduri A; Luppi F; D'Amico R; Balduzzi S; Vicini R; Liverani A; Ruggieri V; Plebani M; Barbaro MP; Spanevello A; Canonica GW; Papi A; Fabbri LM; Beghè B;
PLoS One; 2015; 10(3):e0118241. PubMed ID: 25760346
[TBL] [Abstract][Full Text] [Related]
15. Procalcitonin-guided algorithms of antibiotic therapy in the intensive care unit: a systematic review and meta-analysis of randomized controlled trials.
Kopterides P; Siempos II; Tsangaris I; Tsantes A; Armaganidis A
Crit Care Med; 2010 Nov; 38(11):2229-41. PubMed ID: 20729729
[TBL] [Abstract][Full Text] [Related]
16. Procalcitonin usefulness for the initiation of antibiotic treatment in intensive care unit patients.
Layios N; Lambermont B; Canivet JL; Morimont P; Preiser JC; Garweg C; Ledoux D; Frippiat F; Piret S; Giot JB; Wiesen P; Meuris C; Massion P; Leonard P; Nys M; Lancellotti P; Chapelle JP; Damas P
Crit Care Med; 2012 Aug; 40(8):2304-9. PubMed ID: 22809906
[TBL] [Abstract][Full Text] [Related]
17. Procalcitonin testing to guide antibiotic therapy for the treatment of sepsis in intensive care settings and for suspected bacterial infection in emergency department settings: a systematic review and cost-effectiveness analysis.
Westwood M; Ramaekers B; Whiting P; Tomini F; Joore M; Armstrong N; Ryder S; Stirk L; Severens J; Kleijnen J
Health Technol Assess; 2015 Nov; 19(96):v-xxv, 1-236. PubMed ID: 26569153
[TBL] [Abstract][Full Text] [Related]
18. The Comparison of Procalcitonin Guidance Administer Antibiotics with Empiric Antibiotic Therapy in Critically Ill Patients Admitted in Intensive Care Unit.
Najafi A; Khodadadian A; Sanatkar M; Shariat Moharari R; Etezadi F; Ahmadi A; Imani F; Khajavi MR
Acta Med Iran; 2015; 53(9):562-7. PubMed ID: 26553084
[TBL] [Abstract][Full Text] [Related]
19. Procalcitonin-guided antibiotic therapy duration in critically ill adults.
Walker C
AACN Adv Crit Care; 2015; 26(2):99-106. PubMed ID: 25898876
[TBL] [Abstract][Full Text] [Related]
20. Excluding infection through procalcitonin testing improves outcomes of congestive heart failure patients presenting with acute respiratory symptoms: results from the randomized ProHOSP trial.
Schuetz P; Kutz A; Grolimund E; Haubitz S; Demann D; Vögeli A; Hitz F; Christ-Crain M; Thomann R; Falconnier C; Hoess C; Henzen C; Marlowe RJ; Zimmerli W; Mueller B;
Int J Cardiol; 2014 Aug; 175(3):464-72. PubMed ID: 25005339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
